ARCHIVES

FA Drug Approval on Activity, Rather Than Survival Urged By NCU

This article is from The Cancer Letter archive.

Vol. 15 No. 02 | January 13, 1989

Download PDF Visit The Full Archive

Related Articles

Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS

October 17, 1997

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

California Weighs Listing Tamoxifen As Carcinogen

October 27, 1995

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

June 9, 2006

Cancer Groups Criticize FDA For Ignoring Expert Advice.

November 24, 2000

Postoperative Chemo Doesn’t Improve Survival, Study Finds

March 28, 2008